Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Metastatic Colorectal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT04744831
What this trial is testing

Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Daiichi Sankyo 122
Not applicableStudy completedNCT01843400
What this trial is testing

Regorafenib Post-marketing Surveillance

Who this might be right for
Colorectal Neoplasms
Bayer 1,301
Testing effectiveness (Phase 2)Study completedNCT03519295
What this trial is testing

MDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma

Who this might be right for
Anal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 97
Early research (Phase 1)Study completedNCT00641615
What this trial is testing

Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Kazuhiko Yoshimatsu 18
Testing effectiveness (Phase 2)Study completedNCT00003834
What this trial is testing

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 44
Not applicableNot Yet RecruitingNCT06079242
What this trial is testing

Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
GrandPharma (China) Co., Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT00056030
What this trial is testing

Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 73
Testing effectiveness (Phase 2)Study completedNCT00668863
What this trial is testing

Study Of Sunitinib With FOLFIRI In Colorectal Cancer

Who this might be right for
Unresectable or Metastatic Colorectal Cancer
Pfizer 71
Large-scale testing (Phase 3)Looking for participantsNCT06733038
What this trial is testing

FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 238
Large-scale testing (Phase 3)Study completedNCT02788279
What this trial is testing

Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 363
Large-scale testing (Phase 3)Study completedNCT01307878
What this trial is testing

New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases

Who this might be right for
Colorectal NeoplasmsNeoplasm MetastasisLiver Neoplasms+1 more
Fudan University 320
Not applicableStudy completedNCT05487248
What this trial is testing

On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients

Who this might be right for
Unresectable Locally Advanced Colorectal CancerMetastatic Colorectal CancerCandidate for Third-line or Subsequent Lines of Therapy
Jules Bordet Institute 103
Early research (Phase 1)Not Yet RecruitingNCT07649655
What this trial is testing

EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Unresectable/Metastatic Colorectal Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd. 120
Post-approval studies (Phase 4)Study completedNCT00869271
What this trial is testing

Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer

Who this might be right for
Unresectable Liver Metastasis of Colorectal Cancer
Fudan University 200
Testing effectiveness (Phase 2)Study completedNCT00423696
What this trial is testing

Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
UNICANCER 145
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00103298
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03711058
What this trial is testing

Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer

Who this might be right for
Unresectable or Metastatic Microsatellite Stable (MSS) Solid TumorMicrosatellite Stable (MSS) Colon Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Next Page